Bile Duct Neoplasms: all 220 studies
Page 2 of 3. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Artificial Intelligence for Digital Cholangioscopy Neoplasia DiagnosisCompletedNCT05147389
- Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry.CompletedNCT04937322
- Effect of Materials for Subcuticular Suture (Quill vs. Monocryl) on Complications After Liver ResectionStatus unknownNCT04906174
- Mechanistic Loop Resolution Strategy for Short-type Single Balloon EnteroscopyCompletedNCT04847167Not applicable
- The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary ZoneCompletedNCT04763642Not applicable
- CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsActive, not recruitingNCT04660929Phase 1
- Recurrence After Whipple's (RAW) StudyCompletedNCT04596865
- Nutrition in Gastrointestinal TumorsCompletedNCT04476082
- Irreversible Electroporation of Unresectable Liver TumorsWithdrawnNCT04404647Not applicable
- Two-in-one Covered and Uncovered Metal StentStatus unknownNCT04337333Not applicable
- DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract CancerActive, not recruitingNCT04298021Phase 2
- Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without BevacizumabCompletedNCT04164069Phase 1
- Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.TerminatedNCT04152018Phase 1
- Study of TRIFLURIDINE/TIPIRACIL in Previously Treated CholangiocarcinomaTerminatedNCT04076761Phase 2
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer PainStatus unknownNCT04014478Not applicable
- Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management StudyStatus unknownNCT03951324
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Whole-Exome Sequencing (WES) of Intraductal Neoplasms of the Bile Duct (IPNB)Status unknownNCT03838913
- Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary ObstructionStatus unknownNCT03821025Not applicable
- Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct TractStatus unknownNCT03788655
- PTFE Stents for Treatment of Malignant Biliary StricturesStatus unknownNCT03763214Not applicable
- Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct CancerCompletedNCT03708445Not applicable
- Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct CancerCompletedNCT03679338Phase 2
- A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary CarcinomaStatus unknownNCT03609489Phase 2
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneCompletedNCT03602079Phase 1/2
- Colonization of Bile Ducts and Postoperative Infectious Complications of PancreaticoduodenectomiesCompletedNCT03525067
- Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation ProgramStatus unknownNCT03475966Not applicable
- Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer SurgeryStatus unknownNCT03447691Not applicable
- Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine TumoursTerminatedNCT03328065
- Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic CholangiocarcinomaStatus unknownNCT03086993Phase 2/3
- Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract CancerCompletedNCT03044587Phase 2
- Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct CancersCompletedNCT03003065Phase 2
- Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction PatientStatus unknownNCT02958059Not applicable
- Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting PancreaticoduodenectomyStatus unknownNCT02954302Not applicable
- Extracellular RNA Markers of Liver Disease and CancerTerminatedNCT02908048
- Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic CholangiocarcinomaWithdrawnNCT02856568Phase 1
- Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line ChemotherapyCompletedNCT02853474Phase 3
- Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary StenosisCompletedNCT02841800Not applicable
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
- Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Active, not recruitingNCT02628067Phase 2
- Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct TumoursCompletedNCT02591030Phase 2/3
- Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen TherapyStatus unknownNCT02575014Not applicable
- Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour SurgeryWithdrawnNCT02446379
- Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or GallbladderCompletedNCT02375880Phase 1
- PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary CancerCompletedNCT02088775Not applicable
- Loop-tipped Guidewire in Selective Biliary CannulationCompletedNCT02028845Not applicable
- Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By SurgeryWithdrawnNCT01859182Phase 2
- Study to Compare Cardiovascular Side Effects of Teysuno Versus CapecitabineCompletedNCT01845337Phase 2
- Photodynamic Therapy (PDT) for Palliation of CholangiocarcinomaStatus unknownNCT01755013Phase 2/3
- Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall StonesCompletedNCT01683240Not applicable
- Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesCompletedNCT01643499Phase 1
- Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related SymptomsCompletedNCT01640522Not applicable
- Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar ObstructionWithdrawnNCT01622803Phase 3
- T-EUS for Gastrointestinal Disorders: A Multicenter RegistryStatus unknownNCT01522573
- Stenting Malignant Jaundice for Quality of LifeCompletedNCT01459965Not applicable
- Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter RegistryStatus unknownNCT01439698
- Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersStatus unknownNCT01438385
- A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct CancerStatus unknownNCT01317069Phase 2
- Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by SurgeryCompletedNCT01313377Phase 3
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNCT01282333Phase 1
- Effects of Preoperative Immunonutrition in Patients Undergoing HepatectomyCompletedNCT01256047Phase 4
- Covered or Uncovered Bile Duct StentsCompletedNCT01232101Not applicable
- Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas CancerStatus unknownNCT01111591Phase 4
- Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of OddiCompletedNCT01041612Phase 4
- Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct CarcinomaStatus unknownNCT01016002Phase 2
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
- Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct TumorCompletedNCT00930410Not applicable
- Evaluation of Isolated Roux-en-Y Reconstruction After PancreaticoduodenectomyStatus unknownNCT00915863Not applicable
- Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerCompletedNCT00836992
- Early Enteral Feeding After Pylorus Preserving PancreatoduodenectomyStatus unknownNCT00809081Phase 3
- A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct CancersCompletedNCT00779688
- Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary CancerTerminatedNCT00658593Phase 3
- Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1
- Trial on the Evaluation of Pylorus-ring in PancreaticoduodenectomyCompletedNCT00639314Not applicable
- Randomized Controlled Trial on Pancreatic Stent Tube in PancreaticoduodenectomyCompletedNCT00628186Not applicable
- Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct CancerSuspendedNCT00624182Phase 1
- Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have CancerWithdrawnNCT00588263
- Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractActive, not recruitingNCT00582647
- Quality Of Life in Patients With Malignant Biliary ObstructionCompletedNCT00579865
- Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract CancerCompletedNCT00559598
- Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerCompletedNCT00544193Phase 1
- Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by SurgeryCompletedNCT00513539Phase 3
- Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerCompletedNCT00486356Phase 1
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder CancerWithdrawnNCT00386516Phase 2
- Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract CancerCompletedNCT00363584Phase 3
- HAI Via Interventionally Implanted Port Catheter SystemsStatus unknownNCT00356161Phase 2
- Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By SurgeryCompletedNCT00304135Phase 2/3
- Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary ObstructionCompletedNCT00280709Phase 4
- Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerCompletedNCT00266097Phase 1
- Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract TumorsCompletedNCT00262769Phase 3
- Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By SurgeryWithdrawnNCT00253617Phase 3
- S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00238212Phase 2
- Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal CancersCompletedNCT00183846Phase 1
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
- Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the GallbladderCompletedNCT00084942Phase 2
- Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT00073905Phase 2
- Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerCompletedNCT00059865Phase 1/2
- Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder CancerCompletedNCT00033462Phase 2